• EVALDEZ

    Relief of symptoms of dyspeptic syndrome: bloating, epigastric discomfort, heartburn, belching, nausea, vomiting. Treatment of acute and chronic schizophrenia. This is only the preview. Please…
  • EZATUX

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/EZATUX_0090.T2.pdf"]
  • FLUCOTED

    FLUCOTED is indicated in adults for the treatment of: - Cryptococcal meningitis. - Coccidioidomycosis. - Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria. - Vaginal candidiasis,…
  • FORLEN

    Linezolid is indicated in adult for treatment of the following infections caused by susceptible strains of the designated microorganisms: - Vancomycin-Resistant Enterococcus faecium infections, including…
  • GAYAX

    Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative…
  • GAYAX-400

    Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative…
  • GEBHART

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/GEBHART-CBYT_02.pdf" title="HDSD_GEBHART"]
  • GELLUX

    The short-term (up to 8 weeks) treatment of duodenal ulcer, benign gastric ulcers, chronic gastritis. Prophylaxis of gastrointestinal haemorrhage from stress. Oral ulcers are caused…
  • GIVET-10

    Prophylaxis and chronic treatment of asthma in adults and pediatric patients 6 years and older, including prevention of daytime and nighttime asthma symptoms, treatment of…
  • GLOCKNER-5

    Symptomatic treatment of thyrotoxicosis (including Graves-Basedow’ disease). Treatment of hyperthyroidism in preparation for thyroidectomy until the basal metabolism rate return to normal to prevent possible…
  • GON SA ATZETI

    Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due…
  • GON SA EZETI-10

    Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…